All Pharmaceutical industry articles – Page 3
View all stories with this category.
-
OpinionMay cause side effects
The dose makes the poison, but understanding unwanted drug interactions is complicated
-
Business
Haleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
-
Sponsored
Making quality the priority for fine and specialty chemicals suppliers
Precision measurements and data integrity are essential in pharma and cosmetics supply chains
-
Business
California advances plans to make its own insulin
Governor commits $100 million to develop low-cost insulin and build manufacturing facility to strengthen drug’s supply chain
-
Business
Second Theranos executive convicted of fraud
Blood testing startup president Ramesh ‘Sunny’ Balwani defrauded both investors and patients
-
Business
Novartis cutting up to 8000 jobs
Restructure splits commercial activities geographically instead of by treatment area
-
Opinion
Alzheimer’s, amyloid and abandoned antibodies
Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis?
-
Business
Soapbark branches out to fill essential role in vaccine recipes
The soapbark tree has long been used in traditional medicines, but is now coveted for some of our newest vaccines
-
Feature
Using genetics to personalise prescriptions
We’ve known for a long time that different people respond to certain drugs to very different extents, but now cheap DNA testing could make these disparities a thing of the past, as Ian Le Guillou reports
-
Opinion
Catalogues of complexity
The tangled web of fine chemicals supply frequently throws up surprises
-
Business
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
Feature
The incredible antibodies of sharks, llamas and camels
Sharks and llamas share a strange quirk of their immune systems. Hayley Bennett finds out how their ‘nanobodies’ could help us tackle Covid and a host of other diseases
-
Opinion
Letters: May 2022
Readers reminisce about a smelly interview question and curl up with their favourite arrow-based textbook
-
Opinion
Exit strategy
Overcoming a major setback showed Derek Lowe could make it through graduate school
-
Webinar
Speed up process development by making more from your offline and online data
Learn how the biotechnology R&D team at Clariant uses statistical modelling techniques to speed up the process development of their bio-ethanol product
-
Business
UK takes subscription approach for new antibiotics
Decoupling payment from prescriptions helps preserve last-line antibiotics and encourage R&D
-
Business
Ukraine’s chemicals industry survives weeks of war
Russian invasion pushes firms to the limits as facilities are damaged and distribution networks break down
-
News
UK’s non-profit vaccine manufacturing centre sold off before opening
Pharmaceutical firm Catalent buys government-backed facility near Oxford
-
Feature
A decade of CAR-T cell therapy
Nina Notman looks at the revolutionary treatment already taking on cancer, now aiming for wider use
-
Business
War in Ukraine prompts companies to quit Russia
Sectors supplying medicines and food try to reduce impact on civilians
